Here is a data-driven look at Syngene (SYNGENE), covering financial performance, valuation, and shareholding trends.
Syngene Revenue Trend
At ₹3,739 Cr, Syngene's FY2026 revenue was 2.6% ahead of the ₹3,642 Cr posted in FY2025.
Stepping back, the 10-year revenue CAGR of 12.9% tells a positive story. Syngene has been growing at a solid clip.
With a top line of ₹3,739 Cr, Syngene operates at a mid-sized scale within the miscellaneous sector.
Revenue has moved in the same direction for 10 years running, suggesting the growth trend has structural legs.
| Year | Revenue | YoY % |
|---|---|---|
| FY2026 | ₹3,739 Cr | +2.6% |
| FY2025 | ₹3,642 Cr | +4.4% |
| FY2024 | ₹3,489 Cr | +9.3% |
| FY2023 | ₹3,193 Cr | +22.6% |
| FY2022 | ₹2,604 Cr | — |
View Syngene's full 10-year revenue trend with CAGR analysis →
Syngene Profitability
The bottom line took a hit: Syngene's net profit slipped 36.2% to ₹317 Cr in FY2026.
Margins came under pressure in FY2026, with net profit margin dropping to 8.5% from 13.6%.
At ₹7.87 per share (diluted), FY2026 earnings were down year-over-year from ₹12.34.
Is Syngene Undervalued
Syngene shares are currently trading at ₹402.20.
Craytheon calculates intrinsic value using the P/E Ratio, DCF, and EPS Growth models. All three appear in the Valuation Models cards below.
Valuation Models
Syngene Shareholding Pattern
At 52.6%, the promoter stake has been flat for the past 4 quarters.
On the foreign institutional side, the holding is 11.8% as of June 2026 — down from 16.3%.
The DII stake stands at 28.0% as of June 2026, versus 24.6% in the year-ago period.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Jun 2026 | 52.6% | 11.8% | 28.0% | 7.1% |
| Mar 2026 | 52.7% | 13.9% | 26.4% | 6.7% |
| Dec 2025 | 52.7% | 15.0% | 25.8% | 6.2% |
| Sep 2025 | 52.7% | 16.3% | 24.6% | 6.1% |
Track quarterly shareholding changes for Syngene →
Syngene Balance Sheet
Proportional view as of 3 Aug 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2026 total assets: ₹70.55B (up 3.8% YoY from ₹67.96B).
Top categories: Property, Plant & Equipment (50.8%), Other Assets (25.1%), Cash & ST Investments (9.7%).
Of the ₹70.55B in liabilities and equity, 68.6% is shareholder equity, 6.5% is interest-bearing debt, and 24.9% is operating liabilities. Over the year, debt is down 20.7% and equity is up 2.4%.
Balance sheet composition — FY 2026
| Category | Value |
|---|---|
| Cash & ST Investments | 6.85B |
| Receivables | 5.09B |
| Inventories | 1.41B |
| Property, Plant & Equipment | 35.86B |
| Investments | 3.17B |
| Intangibles & Goodwill | 439.00M |
| Other Assets | 17.74B |
| Category | Value |
|---|---|
| Equity | 48.39B |
| Short-term Debt | 599.00M |
| Long-term Debt | 3.99B |
| Trade Payables | 3.48B |
| Other Liabilities | 14.10B |
Syngene — The Bottom Line
What should investors take away from Syngene's (SYNGENE) latest numbers? Here's the summary.
Revenue of ₹3,739 Cr in FY2026, up 2.6% year-over-year.
Long-term revenue has been compounding at 12.9% annually over 10 years.
The company is profitable, with a net margin of 8.5% and net income of ₹317 Cr.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Syngene's detailed profile on Craytheon.